Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000585170 | SCV000693253 | uncertain significance | not provided | 2017-08-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001084700 | SCV001018681 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002438519 | SCV002748566 | uncertain significance | Cardiovascular phenotype | 2023-01-20 | criteria provided, single submitter | clinical testing | The c.2930-5C>T intronic variant results from a C to T substitution 5 nucleotides upstream from coding exon 20 in the FLNC gene. This nucleotide position is poorly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003900301 | SCV004716598 | likely benign | FLNC-related disorder | 2020-09-29 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |